Skip to main content
| Hans-Günter Meyer-Thompson | Legal

USA. How Rival Opioid Makers Sought To Cash In On Alarm Over OxyContin’s Dangers

USA. How Rival Opioid Makers Sought To Cash In On Alarm Over OxyContin’s Dangers

As Purdue Pharma faced mounting criticism over deaths linked to OxyContin, rival drugmakers saw a chance to boost sales by stepping up marketing of similarly dangerous painkillers, such as fentanyl, morphine and methadone, Purdue internal documents reveal. (Kaiser Health News, USA, 02.08.2018)

https://khn.org/news/how-rival-opioid-makers-sought-to-cash-in-on-alarm-over-oxycontins-dangers